David Windley
Stock Analyst at Jefferies
(4.66)
# 817
Out of 4,376 analysts
806
Total ratings
58.4%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintained: Buy | $135 | $149.45 | -9.67% | 73 | May 28, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $225 | $181.34 | +24.08% | 75 | May 8, 2026 | |
| CNC Centene | Maintained: Hold | $43 → $39 | $62.33 | -37.43% | 88 | Apr 20, 2026 | |
| CI The Cigna Group | Maintained: Buy | $336 → $330 | $289.48 | +14.00% | 64 | Apr 20, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $160 → $139 | $190.86 | -27.17% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $340 → $373 | $399.47 | -6.63% | 73 | Apr 20, 2026 | |
| ELV Elevance Health | Maintained: Buy | $370 → $391 | $415.53 | -5.90% | 77 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgraded: Hold | $12 → $16 | $24.51 | -34.72% | 7 | Apr 20, 2026 | |
| HUM Humana | Maintained: Buy | $235 | $350.08 | -32.87% | 68 | Feb 27, 2026 | |
| MEDP Medpace Holdings | Upgraded: Buy | $450 → $560 | $454.25 | +23.28% | 33 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 → $295 | $314.50 | -6.20% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $18 | $18.46 | -5.20% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $255 | $183.45 | +39.00% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $15.62 | +24.84% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $9.5 | $16.08 | -40.92% | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $3 | $0.8792 | +241.22% | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $263 | $212.35 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $2.5 | $0.1661 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $335 | $172.61 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $15 | $5.37 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $177 → $190 | $51.03 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $248 | $7.05 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $5.00 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $4.22 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $328.53 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $1.73 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $2.70 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $165.44 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $42.80 | n/a | 1 | Aug 27, 2009 |
ICON Public Limited Company
May 28, 2026
Maintained: Buy
Price Target: $135
Current: $149.45
Upside: -9.67%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $225
Current: $181.34
Upside: +24.08%
Centene
Apr 20, 2026
Maintained: Hold
Price Target: $43 → $39
Current: $62.33
Upside: -37.43%
The Cigna Group
Apr 20, 2026
Maintained: Buy
Price Target: $336 → $330
Current: $289.48
Upside: +14.00%
Molina Healthcare
Apr 20, 2026
Maintained: Hold
Price Target: $160 → $139
Current: $190.86
Upside: -27.17%
UnitedHealth Group
Apr 20, 2026
Maintained: Buy
Price Target: $340 → $373
Current: $399.47
Upside: -6.63%
Elevance Health
Apr 20, 2026
Maintained: Buy
Price Target: $370 → $391
Current: $415.53
Upside: -5.90%
Oscar Health
Apr 20, 2026
Upgraded: Hold
Price Target: $12 → $16
Current: $24.51
Upside: -34.72%
Humana
Feb 27, 2026
Maintained: Buy
Price Target: $235
Current: $350.08
Upside: -32.87%
Medpace Holdings
Feb 13, 2026
Upgraded: Buy
Price Target: $450 → $560
Current: $454.25
Upside: +23.28%
Feb 10, 2026
Maintained: Buy
Price Target: $365 → $295
Current: $314.50
Upside: -6.20%
Feb 10, 2026
Maintained: Hold
Price Target: $21 → $18
Current: $18.46
Upside: -5.20%
Feb 6, 2026
Maintained: Buy
Price Target: $225 → $255
Current: $183.45
Upside: +39.00%
Nov 20, 2025
Maintained: Buy
Price Target: $16 → $20
Current: $15.62
Upside: +24.84%
Sep 8, 2025
Maintained: Hold
Price Target: $21 → $9.5
Current: $16.08
Upside: -40.92%
Aug 25, 2025
Maintained: Hold
Price Target: $2.75 → $3
Current: $0.8792
Upside: +241.22%
Jun 4, 2025
Maintained: Hold
Price Target: $263
Current: $212.35
Upside: n/a
Jun 2, 2025
Maintained: Hold
Price Target: $1.5 → $2.5
Current: $0.1661
Upside: n/a
Jun 2, 2025
Maintained: Buy
Price Target: $280 → $335
Current: $172.61
Upside: n/a
Apr 21, 2025
Maintained: Hold
Price Target: $16 → $15
Current: $5.37
Upside: n/a
Apr 26, 2021
Maintained: Buy
Price Target: $177 → $190
Current: $51.03
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $200 → $248
Current: $7.05
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $5.00
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $4.22
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $328.53
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $1.73
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $2.70
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $165.44
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $42.80
Upside: n/a